Ventas
Search documents
Ventas, Inc. (VTR) Presents at BofA Securities 2025 Global Real Estate Conference - Slideshow (NYSE:VTR)
Seeking Alpha· 2025-09-10 20:04
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team ...
Ventas Provides BofA Securities 2025 Global Real Estate Conference Presentation Materials
Businesswire· 2025-09-09 20:57
Core Viewpoint - Ventas, Inc. announced the availability of written materials for its upcoming presentation at the BofA Securities 2025 Global Real Estate Conference, scheduled for September 10, 2025 [1] Company Information - The written materials can be accessed on the Company's website at ir.ventasreit.com/events-and-presentations [1] - A webcast of the Company's presentation at the BofA Securities Conference will also be available on its website [1]
Ventas Releases 2024-2025 Corporate Sustainability Report
Businesswire· 2025-09-08 21:00
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) ("Ventas†or the "Company†) today announced the release of its 2024-2025 Corporate Sustainability Report ("CSR†). The report outlines the Company's corporate sustainability initiatives that are designed to support growth and value creation as Ventas capitalizes on accelerating demand for senior housing and enables exceptional environments that benefit a large and growing aging population. The CSR is available at https://www.ventasreit.com/csr20. ...
Ventas to Participate in Investor Meetings at BofA Securities 2025 Global Real Estate Conference
Businesswire· 2025-09-08 20:45
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) ("Ventas†or the "Company†) announced today that management will participate in investor meetings at the BofA Securities 2025 Global Real Estate Conference (the "BofA Securities Conference†) on September 10, 2025 and will make a presentation at 3:45 p.m. Eastern Time. The webcast will be accessible on the Company's website at ir.ventasreit.com/events-and-presentations. Any Company written materials accompanying the presentation at the BofA Secu. ...
CNBC Property Play: Aging boomers could mean big business for senior living
CNBC Television· 2025-08-20 19:02
Market Trends & Industry Dynamics - Senior living is on the edge of a boom due to the aging baby boomer population, with over 4 million boomers expected to reach 80 in the next five years [1][2][3] - The over 80 population is expected to grow by 28% in the next five years, significantly outpacing the overall US population growth of about 1% [3] - Annual inventory growth in senior living has dropped below 1% for the first time since 2006, indicating constrained supply [1] - Demand-supply dynamics strongly favor owners of senior living assets due to decade-long tailwinds and historically low supply growth [5] - The senior living sector is becoming increasingly consumer-driven, with residents paying out-of-pocket for care and amenities [25][26] - The great investment opportunities always go back to where is the demand, senior living is such a great investment opportunity is that the demand is in this longevity economy [32][34] Investment Opportunities & Financial Performance - Ventas is investing billions of dollars annually in senior living, seeing returns in the 7% range going in, with unlevered IRR in the low to mid teens, and acquiring assets below replacement costs [1][3] - Baby boomers, who are now turning 80, control $78 trillion, which is half the assets in the US, with the average net worth of over 75 household is 1 million plus [12] - Ventas benefits from higher development costs because it has an installed base and is acquiring assets below replacement cost [14] - Ventas has wildly outperformed the S&P 500 during the CEO's tenure [31] Risks & Challenges - Potential risks include macroeconomic factors like stagflation or recession, and ensuring sufficient caregivers and labor [21][22] - Scarcity of construction labor and tariffs will keep construction costs relatively elevated [23]
Ventas Stock Gains 15.5% Year to Date: Will It Continue to Rise?
ZACKS· 2025-08-20 14:36
Core Insights - Ventas (VTR) shares have increased by 15.5% year to date, significantly outperforming the industry growth of 0.9% [1][8] - The company is well-positioned for growth due to rising healthcare spending and an aging population, which will benefit its senior housing operating portfolio (SHOP) [1][5] - Ventas has made substantial investments in its research portfolio and maintains a solid balance sheet, which supports its growth prospects [1][9] Financial Performance - In Q2 2025, Ventas reported normalized funds from operations (FFO) per share of 87 cents, exceeding the Zacks Consensus Estimate of 85 cents, and reflecting a 9% increase from the previous year [2][8] - The company has raised its guidance for 2025 normalized FFO per share, indicating positive expectations for future performance [2][3] Market Position and Growth Drivers - The senior citizen population is projected to grow, leading to increased healthcare expenditures, which Ventas is poised to capitalize on due to low new supply in its markets [5][6] - Ventas' senior housing portfolio is strategically located in markets with favorable demographics and strong net absorption, enhancing growth potential [6][9] - The company has invested $1.1 billion in senior housing from the beginning of the year through July 30, 2025, with expectations of 12% to 16% growth in same-store cash NOI for its SHOP segment in 2025 [6][8] Strategic Initiatives - Ventas is focusing on outpatient medical and research (OM&R) portfolio growth, driven by an increase in outpatient visits among the aging population [7] - The company is enhancing its liquidity position, with approximately $4.7 billion in liquidity as of June 30, 2025, and has improved its net debt to further adjusted EBITDA ratio [10]
Ventas Selects Discovery Senior Living to Operate its 15 Communities
ZACKS· 2025-08-11 18:16
Core Insights - Ventas, Inc. has selected Discovery Senior Living to manage 15 senior living communities across multiple U.S. states, indicating a long-term partnership focused on operational excellence and value creation [1][4] - The communities will be integrated into three of Discovery's Management Companies, which will utilize specialized practices and market insights to enhance performance [2][9] - The partnership has shown consistent development since 2021, with the potential for increased occupancy in the newly managed communities [3] Transition Details - Discovery will begin operations for specific communities in September, with a complete transition expected by the end of 2025 [4][9] - The transition aims to align both companies in terms of operational excellence and resident satisfaction [4] Company Performance - Ventas has a diverse portfolio of healthcare real estate assets in key U.S. and U.K. markets, positioning it to benefit from favorable industry fundamentals [5] - The company has experienced a 5.3% increase in shares over the past three months, contrasting with a 0.7% decline in the industry [6]
Discovery Senior Living Selected to Operate 15 Ventas-Owned Communities, Expanding Discovery's Portfolio and Strategic Relationship
Newsfile· 2025-08-08 13:02
Core Insights - Discovery Senior Living has been selected by Ventas, Inc. to operate 15 senior living communities across multiple U.S. states, marking an expansion of their multi-year relationship focused on operational excellence and long-term value creation [1][3]. Group 1: Operational Transition - Discovery is set to begin operations for select communities in September 2025, with all communities transitioning by the end of 2025 [2]. - The 15 communities will be integrated into three of Discovery's Management Companies (ManCos): Integral Senior Living (ISL), Discovery Management Group (DMG), and Terrabella Senior Living, which are designed to optimize performance through tailored operating practices [2][4]. Group 2: Strategic Relationship - The expansion of the relationship with Ventas is seen as a significant milestone, reflecting confidence in Discovery's ability to create exceptional living environments for seniors [3]. - Since 2021, the relationship has grown based on strong operational performance and collaboration, with the 15 communities having significant occupancy potential [3][4]. Group 3: Market Position and Performance - Discovery operates over 140 communities in the states where the new assets are located, allowing for immediate synergies and operational leverage [4]. - The company is positioned to capitalize on historic demand growth in senior housing, supported by a unique operating platform that combines local execution with national support [5][8]. Group 4: Company Overview - Discovery Senior Living is the largest privately held operator in the U.S., with nearly 40,000 units across more than 360 communities in nearly 40 states [8]. - The company has over 18,000 employees and is recognized for performance, innovation, and customized lifestyle experiences, having been certified as a Great Place To Work for four consecutive years [8].
Ventas(VTR) - 2025 Q2 - Quarterly Report
2025-07-31 20:25
PART I—FINANCIAL INFORMATION [Item 1. Consolidated Financial Statements (Unaudited)](index=3&type=section&id=Item%201.%20Consolidated%20Financial%20Statements%20(Unaudited)) This section presents Ventas, Inc.'s unaudited consolidated financial statements, including balance sheets, statements of income, comprehensive income, equity, and cash flows, along with detailed notes explaining accounting policies, business segments, credit risk, acquisitions, dispositions, debt, and other financial instruments [Consolidated Balance Sheets](index=3&type=section&id=Consolidated%20Balance%20Sheets) - Total assets **increased by** **$288 million** from December 31, 2024, to June 30, 2025, while total liabilities **decreased by** **$493 million**, leading to a **$762.8 million** **increase** in total equity[8](index=8&type=chunk) | Metric | As of June 30, 2025 (in thousands) | As of December 31, 2024 (in thousands) | | :--------------------------------- | :---------------------------------- | :----------------------------------- | | Total assets | $26,474,929 | $26,186,906 | | Total liabilities | $14,553,769 | $15,047,081 | | Total equity | $11,592,461 | $10,829,596 | [Consolidated Statements of Income](index=5&type=section&id=Consolidated%20Statements%20of%20Income) - For the six months ended June 30, 2025, total revenues **increased by** **$378.07 million** (**15.7%**) year-over-year, and net income attributable to common stockholders **significantly increased by** **$110.06 million**, resulting in a diluted EPS of **$0.25**, **up from** **$0.01** in the prior year[10](index=10&type=chunk) | Metric | Three Months Ended June 30, 2025 (in thousands) | Three Months Ended June 30, 2024 (in thousands) | Six Months Ended June 30, 2025 (in thousands) | Six Months Ended June 30, 2024 (in thousands) | | :---------------------------------- | :---------------------------------------------- | :---------------------------------------------- | :-------------------------------------------- | :-------------------------------------------- | | Total revenues | $1,420,893 | $1,200,980 | $2,778,967 | $2,400,894 | | Total expenses | $1,378,235 | $1,220,064 | $2,695,368 | $2,427,480 | | Net income | $71,462 | $21,168 | $119,818 | $8,628 | | Net income attributable to common stockholders | $68,264 | $19,387 | $115,132 | $5,075 | | Basic EPS attributable to common stockholders | $0.15 | $0.05 | $0.26 | $0.01 | | Diluted EPS attributable to common stockholders | $0.15 | $0.05 | $0.25 | $0.01 | [Consolidated Statements of Comprehensive Income](index=7&type=section&id=Consolidated%20Statements%20of%20Comprehensive%20Income) - For the six months ended June 30, 2025, comprehensive income attributable to common stockholders **increased by** **$91.43 million** (**390.3%**) year-over-year, **primarily driven by** higher net income[12](index=12&type=chunk) | Metric | Three Months Ended June 30, 2025 (in thousands) | Three Months Ended June 30, 2024 (in thousands) | Six Months Ended June 30, 2025 (in thousands) | Six Months Ended June 30, 2024 (in thousands) | | :------------------------------------------ | :---------------------------------------------- | :---------------------------------------------- | :-------------------------------------------- | :-------------------------------------------- | | Net income | $71,462 | $21,168 | $119,818 | $8,628 | | Total other comprehensive income | $3,015 | $777 | $3,468 | $15,854 | | Comprehensive income | $74,477 | $21,945 | $123,286 | $24,482 | | Comprehensive income attributable to common stockholders | $66,531 | $21,532 | $114,854 | $23,423 | [Consolidated Statements of Equity](index=8&type=section&id=Consolidated%20Statements%20of%20Equity) - Total Ventas stockholders' equity **increased by** **$758.12 million** from December 31, 2024, to June 30, 2025, **primarily due to** net income and issuance of common stock for stock plans, restricted stock grants and other, **partially offset by** dividends[19](index=19&type=chunk) | Metric | As of June 30, 2025 (in thousands) | As of December 31, 2024 (in thousands) | | :--------------------------------- | :--------------------------------- | :--------------------------------- | | Total Ventas stockholders' equity | $11,529,388 | $10,771,267 | | Noncontrolling interests | $63,073 | $58,329 | | Total equity | $11,592,461 | $10,829,596 | [Consolidated Statements of Cash Flows](index=12&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows) - Net cash **provided by** operating activities **increased by** **$194.16 million** (**32.2%**) year-over-year for the six months ended June 30, 2025[22](index=22&type=chunk) - Net cash **used in** investing activities **increased significantly by** **$676.78 million** (**164.5%**) **due to** higher real estate investments[22](index=22&type=chunk)[297](index=297&type=chunk)[298](index=298&type=chunk) - Financing activities **shifted from a net cash use** to a **net cash provision**, **increasing by** **$143.26 million** (**105.8%**)[22](index=22&type=chunk)[297](index=297&type=chunk)[298](index=298&type=chunk)[299](index=299&type=chunk) | Cash Flow Activity | Six Months Ended June 30, 2025 (in thousands) | Six Months Ended June 30, 2024 (in thousands) | | :--------------------------------- | :-------------------------------------------- | :-------------------------------------------- | | Net cash provided by operating activities | $796,482 | $602,320 | | Net cash used in investing activities | $(1,088,164) | $(411,387) | | Net cash provided by (used in) financing activities | $7,830 | $(135,427) | | Net (decrease) increase in cash, cash equivalents and restricted cash | $(283,852) | $55,506 | [Notes to Consolidated Financial Statements](index=15&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) [NOTE 1—DESCRIPTION OF BUSINESS](index=15&type=section&id=NOTE%201—DESCRIPTION%20OF%20BUSINESS) Ventas, Inc. is a REIT focused on healthcare real estate, including senior housing, medical buildings, research centers, and hospitals across North America and the UK. The company operates through three reportable segments: SHOP, OM&R, and NNN, with performance evaluated based on Net Operating Income (NOI) - Ventas, Inc. is a REIT with **1,395 properties** as of June 30, 2025, serving a growing aging population[27](index=27&type=chunk) | Segment | NOI (Six Months Ended June 30, 2025, in thousands) | Percentage of Total NOI | Segment Properties | | :-------------------------------- | :------------------------------------------------- | :---------------------- | :------------------- | | Senior housing operating portfolio (SHOP) | $550,916 | **47.6%** | 683 | | Outpatient medical and research portfolio (OM&R) | $292,528 | **25.3%** | 415 | | Triple-net leased properties (NNN) | $301,322 | **26.0%** | 259 | | Non-segment | $12,647 | **1.1%** | n/a | | Total | $1,157,413 | **100.0%** | **1,357** | [NOTE 2—ACCOUNTING POLICIES](index=16&type=section&id=NOTE%202—ACCOUNTING%20POLICIES) This note outlines the company's adherence to GAAP for interim financial reporting, including the use of estimates and principles of consolidation. It also details recent accounting standards updates, such as ASU 2023-09 (Income Tax Disclosures), SEC Release No. 33-11275 (Climate-Related Disclosures), and ASU 2024-03 (Disaggregation of Income Statement Expenses), and their potential impact - ASU 2023-09 (Improvements to Income Tax Disclosures) is **effective** for fiscal years beginning after December 15, 2024, requiring specific categories in rate reconciliation and additional information for significant reconciling items[39](index=39&type=chunk) - The SEC's climate-related disclosure rule (SEC Release No. 33-11275) is **effective** for annual reporting periods beginning in fiscal year 2025, though it is currently stayed and under judicial review[40](index=40&type=chunk) - ASU 2024-03 (Disaggregation of Income Statement Expenses) is **effective** for annual reporting periods beginning after December 15, 2026, requiring footnote disclosure of disaggregated income statement expenses[41](index=41&type=chunk) [NOTE 3—CONCENTRATION OF CREDIT RISK](index=17&type=section&id=NOTE%203—CONCENTRATION%20OF%20CREDIT%20RISK) Ventas is exposed to credit risk from tenants in its NNN and OM&R segments, as these tenants are obligated to pay rent and property-related expenses. The note summarizes the contribution of major tenants (Brookdale, Ardent, Kindred) to total revenues and NOI - All Brookdale and Kindred rent, and **substantially all** Ardent rent, is guaranteed by a corporate parent[46](index=46&type=chunk) | Tenant | Contribution as a Percentage of Total Revenues (Q2 2025) | Contribution as a Percentage of Total Revenues (Q2 2024) | Contribution as a Percentage of Total NOI (Q2 2025) | Contribution as a Percentage of Total NOI (Q2 2024) | | :------- | :------------------------------------------------------- | :------------------------------------------------------- | :------------------------------------------------ | :------------------------------------------------ | | Brookdale | **2.8%** | **3.1%** | **6.8%** | **7.2%** | | Ardent | **2.7%** | **3.1%** | **6.5%** | **7.3%** | | Kindred | **2.5%** | **2.8%** | **5.9%** | **6.6%** | [NOTE 4—ACQUISITIONS OF REAL ESTATE PROPERTY](index=18&type=section&id=NOTE%204—ACQUISITIONS%20OF%20REAL%20ESTATE%20PROPERTY) Ventas acquires healthcare properties to grow and diversify its portfolio. In the first half of 2025, the company acquired 23 senior housing communities, with additional acquisitions in July 2025 - During the six months ended June 30, 2025, Ventas **Acquired** **23 senior housing communities** in its SHOP segment for an aggregate purchase price of **$961.5 million**[51](index=51&type=chunk) - In July 2025, Ventas **Acquired** an additional **five senior housing communities** in its SHOP segment for **$147.7 million**[51](index=51&type=chunk) [NOTE 5—DISPOSITIONS, ASSETS HELD FOR SALE AND IMPAIRMENTS](index=20&type=section&id=NOTE%205—DISPOSITIONS,%20ASSETS%20HELD%20FOR%20SALE%20AND%20IMPAIRMENTS) This note details the company's property dispositions, assets classified as held for sale, and real estate impairment charges recognized during the reporting periods - For the six months ended June 30, 2025, Ventas **Sold** **one SHOP community** and **10 NNN properties** for **$159.0 million**, recognizing a **$13.2 million gain**[52](index=52&type=chunk) - In June 2025, a sales-type lease for **12 OM&R properties** resulted in a **$20.8 million gain** on real estate disposition[54](index=54&type=chunk) - Real estate impairments for the six months ended June 30, 2025, totaled **$57.2 million**, **primarily in** SHOP (**$26.0 million**) and OM&R (**$31.1 million**), **due to** changes in intent to hold or expected future cash flows[56](index=56&type=chunk) | Segment | Properties Held for Sale (June 30, 2025) | Assets Held for Sale (June 30, 2025, in thousands) | Liabilities Related to Assets Held for Sale (June 30, 2025, in thousands) | | :------ | :--------------------------------------- | :------------------------------------------------- | :------------------------------------------------------------------------ | | SHOP | 4 | $41,608 | $2,852 | | OM&R | 3 | $7,328 | $401 | | NNN | 2 | $1,156 | $189 | | Total | 9 | $50,092 | $3,442 | [NOTE 6—LOANS RECEIVABLE AND INVESTMENTS, NET](index=21&type=section&id=NOTE%206—LOANS%20RECEIVABLE%20AND%20INVESTMENTS,%20NET) This note provides a summary of Ventas's loans receivable and investments, categorized as secured loans receivable and non-mortgage loans receivable, which relate to senior housing and healthcare operators or properties - Total loans receivable and investments, net, **increased by** **$31.57 million** from December 31, 2024, to June 30, 2025[59](index=59&type=chunk) | Category | Carrying Amount as of June 30, 2025 (in thousands) | Carrying Amount as of December 31, 2024 (in thousands) | | :------------------------------------ | :----------------------------------------------- | :----------------------------------------------- | | Secured loans receivable and investments, net | $183,652 | $144,872 | | Non-mortgage loans receivable, net | $20,915 | $28,129 | | Total loans receivable and investments, net | $204,567 | $173,001 | [NOTE 7—INVESTMENTS IN UNCONSOLIDATED ENTITIES](index=21&type=section&id=NOTE%207—INVESTMENTS%20IN%20UNCONSOLIDATED%20ENTITIES) Ventas holds equity method investments in unconsolidated real estate entities, including the Ventas Fund, and operating entities like Atria and Ardent, providing various services for fees - Management fees **earned from** unconsolidated real estate entities were **$7.8 million** for the six months ended June 30, 2025, **up from** **$7.7 million** in the prior year[63](index=63&type=chunk) - Ventas holds a **34%** ownership interest in Atria and an approximately **6.7%** ownership interest in Ardent[64](index=64&type=chunk)[65](index=65&type=chunk) | Investment | Carrying Amount as of June 30, 2025 (in thousands) | Carrying Amount as of December 31, 2024 (in thousands) | | :------------------------------------ | :----------------------------------------------- | :----------------------------------------------- | | Ventas Fund | $274,774 | $267,202 | | Research & Innovation Development Joint Venture | $301,526 | $309,499 | | Total investments in unconsolidated real estate entities | $626,571 | $626,122 | [NOTE 8—INTANGIBLES](index=23&type=section&id=NOTE%208—INTANGIBLES) This note provides a summary of Ventas's intangible assets and liabilities, including above-market lease intangibles, in-place lease and other real estate intangibles, goodwill, and below-market lease intangibles - Net intangible assets **slightly decreased by** **$0.57 million**, while net intangible liabilities **decreased by** **$5.11 million** from December 31, 2024, to June 30, 2025[68](index=68&type=chunk) | Category | Balance as of June 30, 2025 (in thousands) | Balance as of December 31, 2024 (in thousands) | | :--------------------------------- | :----------------------------------------- | :----------------------------------------- | | Acquired lease intangibles | $1,556,165 | $1,558,751 | | Goodwill | $1,046,384 | $1,044,915 | | Net intangible assets | $1,357,915 | $1,358,482 | | Net intangible liabilities | $70,085 | $75,197 | [NOTE 9—OTHER ASSETS](index=24&type=section&id=NOTE%209—OTHER%20ASSETS) This note summarizes the components of Ventas's 'Other assets,' which include straight-line rent receivables, deferred lease costs, accounts receivable, investments in unconsolidated operating entities, and other items like stock warrants - Total Other assets **decreased by** **$58.76 million** from December 31, 2024, to June 30, 2025, **primarily due to a decrease** in accounts receivable and other assets, **including** the exercise and sale of Brookdale Warrants[71](index=71&type=chunk) | Category | As of June 30, 2025 (in thousands) | As of December 31, 2024 (in thousands) | | :--------------------------------- | :--------------------------------- | :--------------------------------- | | Straight-line rent receivables | $219,331 | $202,675 | | Deferred lease costs, net | $152,846 | $145,973 | | Accounts receivable, net | $72,400 | $108,138 | | Investment in unconsolidated operating entities | $99,827 | $95,623 | | Total Other assets | $733,902 | $792,663 | [NOTE 10—SENIOR NOTES PAYABLE AND OTHER DEBT](index=25&type=section&id=NOTE%2010—SENIOR%20NOTES%20PAYABLE%20AND%20OTHER%20DEBT) This note details Ventas's debt structure, including senior notes, credit facilities, commercial paper, and term loans. It also covers derivative instruments used for hedging interest rate risk and provides a schedule of debt maturities - Ventas **repaid** **$450.0 million** of 2.65% Senior Notes and **$600.0 million** of 3.50% Senior Notes in January and February 2025, respectively[89](index=89&type=chunk) - In June 2025, Ventas Realty **issued** **$500.0 million** of **5.10%** Senior Notes due 2032[89](index=89&type=chunk) - As of June 30, 2025, Ventas had a **$3.5 billion** unsecured revolving credit facility with **$1.4 million** **outstanding** and **$0.8 million** **restricted for letters of credit**[77](index=77&type=chunk)[79](index=79&type=chunk) - For the six months ended June 30, 2025, Ventas **entered into** **$200.0 million** notional amount of 10-year treasury locks to hedge interest rate risk on future debt issuances[99](index=99&type=chunk) | Debt Type | As of June 30, 2025 (in thousands) | As of December 31, 2024 (in thousands) | | :--------------------------------- | :--------------------------------- | :--------------------------------- | | Senior notes payable and other debt | $13,056,312 | $13,522,551 | | Maturity Year | Total Maturities (in thousands) | | :-------------- | :------------------------------ | | 2025 | $550,987 | | 2026 | $2,110,232 | | 2027 | $1,634,616 | | 2028 | $1,570,363 | | 2029 | $1,701,145 | | Thereafter | $5,587,531 | | Total | $13,154,874 | [NOTE 11—FAIR VALUES OF FINANCIAL INSTRUMENTS](index=30&type=section&id=NOTE%2011—FAIR%20VALUES%20OF%20FINANCIAL%20INSTRUMENTS) This note provides an overview of fair value measurements for financial instruments, classifying them into Level 1, 2, and 3 hierarchies based on input observability. It summarizes the carrying amounts and fair values of assets and liabilities measured on a recurring or nonrecurring basis - Derivative instrument assets **primarily consist of** interest rate swaps (Level 2) and Scion Warrants (Level 3)[107](index=107&type=chunk) - Real estate impairment charges are **generally measured using** Level 3 inputs, based on company-specific assumptions about marketability, net operating income, and capitalization/discount rates[110](index=110&type=chunk) | Financial Instrument | Carrying Amount (June 30, 2025, in thousands) | Fair Value (June 30, 2025, in thousands) | | :--------------------------------- | :-------------------------------------------- | :--------------------------------------- | | Cash and cash equivalents | $614,200 | $614,200 | | Secured loans receivable and investments, net | $183,652 | $184,534 | | Senior notes payable and other debt, gross | $13,154,874 | $13,135,881 | | Derivative instruments (assets) | $22,286 | $22,286 | | Derivative instruments (liabilities) | $7,365 | $7,365 | [NOTE 12—COMMITMENTS AND CONTINGENCIES](index=32&type=section&id=NOTE%2012—COMMITMENTS%20AND%20CONTINGENCIES) Ventas is involved in various legal proceedings and may be contractually obligated to indemnify third parties. The company also provides guarantees and similar contingent obligations, none of which have triggered a liability as of June 30, 2025 - Management believes current legal proceedings will not have a **material adverse effect** on the company[112](index=112&type=chunk) - As of June 30, 2025, **no triggering events** related to guarantees, indemnities, or similar contingent obligations have occurred, so no contingent liability is recorded[116](index=116&type=chunk) [NOTE 13—INCOME TAXES](index=33&type=section&id=NOTE%2013—INCOME%20TAXES) Ventas operates as a REIT, generally exempt from U.S. federal corporate income taxes on distributed income, but its Taxable REIT Subsidiaries (TRSs) are subject to federal, state, and foreign income taxes. The note details the income tax provision/benefit and factors influencing it - The six months ended June 30, 2025, saw an **income tax benefit** of **$6.7 million**, **primarily due to the reversal** of valuation allowances against net deferred tax assets of certain TRS entities[119](index=119&type=chunk) - The **income tax expense** for the three and six months ended June 30, 2024, was **primarily due to the enactment** of Bill C-59 in Canada, limiting interest expense deductions for Canadian entities[119](index=119&type=chunk) | Metric | Three Months Ended June 30, 2025 (in thousands) | Three Months Ended June 30, 2024 (in thousands) | Six Months Ended June 30, 2025 (in thousands) | Six Months Ended June 30, 2024 (in thousands) | | :------------------------- | :---------------------------------------------- | :---------------------------------------------- | :-------------------------------------------- | :-------------------------------------------- | | Consolidated provision for income taxes | $(3,874) | $(7,766) | $6,683 | $(4,762) | [NOTE 14—STOCKHOLDERS' EQUITY](index=34&type=section&id=NOTE%2014—STOCKHOLDERS'%20EQUITY) This note outlines changes in stockholders' equity, including the At-The-Market (ATM) offering program for common stock sales, an increase in authorized common stock, and the components of accumulated other comprehensive loss - In June 2025, the ATM Sales Agreement was **amended**, **increasing the aggregate gross sales price** of common stock available for issuance to **$2.25 billion**, with **$2.0 billion** **remaining available** as of June 30, 2025[123](index=123&type=chunk) - During the six months ended June 30, 2025, Ventas **entered into equity forward sales agreements** for **22.8 million shares**, **generating gross proceeds of** **$1.5 billion**, and **settled** **16.4 million shares** for **$1.1 billion** **net cash proceeds**[125](index=125&type=chunk) - In May 2025, stockholders **approved an increase** in authorized common stock from **600 million** to **1.2 billion shares**[128](index=128&type=chunk) | Component | As of June 30, 2025 (in thousands) | As of December 31, 2024 (in thousands) | | :--------------------------------- | :--------------------------------- | :--------------------------------- | | Foreign currency translation loss | $(28,622) | $(34,341) | | Unrealized loss on available for sale securities | $(1,500) | $(2,118) | | Unrealized (loss) gain on derivative instruments | $(3,682) | $2,933 | | Total Accumulated other comprehensive loss | $(33,804) | $(33,526) | [NOTE 15—EARNINGS PER SHARE](index=35&type=section&id=NOTE%2015—EARNINGS%20PER%20SHARE) This note provides the calculation of basic and diluted earnings per share (EPS) for common stockholders, detailing the numerator (net income attributable to common stockholders) and denominator (weighted average shares outstanding, adjusted for dilutive securities) - The **dilutive effect** of Exchangeable Notes was **included in** the computation of diluted EPS for the three and six months ended June 30, 2025, but was **antidilutive** in the prior year periods[133](index=133&type=chunk) | Metric | Three Months Ended June 30, 2025 | Three Months Ended June 30, 2024 | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :------------------------------------------ | :------------------------------- | :------------------------------- | :----------------------------- | :----------------------------- | | Net income attributable to common stockholders | $68,264 (in thousands) | $19,387 (in thousands) | $115,132 (in thousands) | $5,075 (in thousands) | | Basic EPS attributable to common stockholders | $0.15 | $0.05 | $0.26 | $0.01 | | Diluted EPS attributable to common stockholders | $0.15 | $0.05 | $0.25 | $0.01 | | Weighted average shares (basic) | 452,583 (in thousands) | 408,097 (in thousands) | 446,314 (in thousands) | 405,747 (in thousands) | | Weighted average shares (diluted) | 459,088 (in thousands) | 411,823 (in thousands) | 453,000 (in thousands) | 409,472 (in thousands) | [NOTE 16—SEGMENT INFORMATION](index=36&type=section&id=NOTE%2016—SEGMENT%20INFORMATION) Ventas operates through three reportable business segments: Senior Housing Operating Portfolio (SHOP), Outpatient Medical and Research Portfolio (OM&R), and Triple-Net Leased Properties (NNN). The Chief Operating Decision Maker (CODM) evaluates segment performance and allocates resources based on Net Operating Income (NOI) - SHOP segment NOI **increased by** **33.7%** for Q2 2025 and **31.9%** for YTD Q2 2025, **driven by** revenue growth from **increased occupancy** and **revenue per occupied room**, and net acquisitions[195](index=195&type=chunk)[222](index=222&type=chunk) - OM&R segment NOI **increased marginally by** **0.1%** for Q2 2025 and **0.2%** for YTD Q2 2025, **primarily due to** **new leasing activity** and **high tenant retention**[199](index=199&type=chunk)[227](index=227&type=chunk) - NNN segment NOI **decreased by** **1.1%** for Q2 2025 and **0.2%** for YTD Q2 2025, **mainly due to** properties converting to SHOP and dispositions, **partially offset by** acquisitions and contractual rent escalators[202](index=202&type=chunk)[229](index=229&type=chunk) | Segment | Total Revenues (Q2 2025, in thousands) | NOI (Q2 2025, in thousands) | Total Revenues (YTD Q2 2025, in thousands) | NOI (YTD Q2 2025, in thousands) | | :-------------------------------- | :------------------------------------- | :-------------------------- | :----------------------------------------- | :------------------------------ | | SHOP | $1,032,714 | $286,412 | $2,001,618 | $550,916 | | OM&R | $221,487 | $146,486 | $443,486 | $292,528 | | NNN | $152,702 | $148,736 | $308,815 | $301,322 | | Non-Segment | $13,990 | $6,492 | $25,048 | $12,647 | | Total | $1,420,893 | $588,126 | $2,778,967 | $1,157,413 | [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=41&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) This section provides management's perspective on Ventas, Inc.'s financial condition and results of operations, including an overview of the company, business strategy, market trends, 2025 highlights, new legislation impacts, critical accounting policies, and detailed analysis of financial performance for the three and six months ended June 30, 2025 and 2024 [Cautionary Statements](index=41&type=section&id=Cautionary%20Statements) This section highlights that the report contains forward-looking statements subject to various uncertainties and factors that could cause actual results to differ materially. It advises careful review of risks and uncertainties affecting the business and future financial performance - Forward-looking statements are based on management's beliefs and assumptions, but actual events or results could differ materially **due to** numerous uncertainties and factors[156](index=156&type=chunk) - Key risk factors **include** exposure to evolving governmental policies, macroeconomic conditions (inflation, interest rates), potential legal actions, reliance on third-party managers, access to capital markets, and ability to navigate industry trends[157](index=157&type=chunk) [Company Overview](index=43&type=section&id=Company%20Overview) Ventas, Inc. is a REIT specializing in healthcare real estate, including senior housing, medical buildings, and research centers across North America and the UK. It operates through SHOP, OM&R, and NNN segments, with performance evaluated by NOI - Ventas owns or has investments in **1,395 properties** as of June 30, 2025, with **1,357** in reportable segments and **38** in unconsolidated entities[160](index=160&type=chunk) - The company maintains REIT status, which generally exempts it from U.S. federal corporate income taxes on distributed taxable income[161](index=161&type=chunk) | Segment | Total NOI (Six Months Ended June 30, 2025, in thousands) | Percentage of Total NOI | | :-------------------------------- | :------------------------------------------------- | :---------------------- | | Senior housing operating portfolio (SHOP) | $550,916 | **47.6%** | | Outpatient medical and research portfolio (OM&R) | $292,528 | **25.3%** | | Triple-net leased properties (NNN) | $301,322 | **26.0%** | | Non-segment | $12,647 | **1.1%** | | Total | $1,157,413 | **100.0%** | [Business Strategy](index=44&type=section&id=Business%20Strategy) Ventas's enduring strategy focuses on delivering shareholder value by enabling exceptional environments for the aging population. Key objectives include profitable organic growth in senior housing, value-creating external growth, strong execution across its portfolio, and maintaining financial strength - The strategy aims for consistent, superior total returns through profitable organic growth in senior housing, value-creating external growth, strong execution, and maintaining financial strength, flexibility, and liquidity[166](index=166&type=chunk) - The objective is to generate reliable and growing cash flows to support regular cash dividends and **increase** stockholder value[167](index=167&type=chunk) [Market Trends](index=44&type=section&id=Market%20Trends) Ventas's operations are influenced by economic and market conditions. The senior housing sector is expected to benefit from strong supply/demand fundamentals, including robust demand growth and low projected supply growth. Broader macroeconomic factors like interest rates and inflation also impact business performance - Senior housing is **expected to benefit from** **strong supply/demand fundamentals**, characterized by **robust projected demand growth** and **low projected supply growth**[168](index=168&type=chunk) - Business performance and growth are **dependent on** the broader macroeconomic environment, **including** consumer sentiment, interest rates, inflation, and GDP growth[168](index=168&type=chunk) [2025 Highlights](index=44&type=section&id=2025%20Highlights) Key highlights for 2025 **include** significant acquisitions in senior housing, strategic dispositions, enhanced liquidity through an increased revolving credit facility, repayment of senior notes, and active equity offerings - **Acquired** **23 senior housing communities** for **$961.5 million** during the six months ended June 30, 2025, and an additional **five senior housing communities** for **$147.7 million** in July 2025[172](index=172&type=chunk) - **Sold** **one senior housing community** and **10 NNN properties** for **$159.0 million**, recognizing a **$13.2 million gain**, and a sales-type lease for **12 OM&R properties** resulted in a **$20.8 million gain**[172](index=172&type=chunk) - **Achieved** **$4.7 billion** in liquidity as of June 30, 2025, **including** **$3.5 billion** availability under the unsecured revolving credit facility (**increased from** **$2.75 billion** in April 2025)[172](index=172&type=chunk) - **Repaid** **$1.05 billion** in senior notes due 2025 and **issued** **$500.0 million** of **5.10%** Senior Notes due 2032[178](index=178&type=chunk) - **Entered into equity forward sales agreements** for **24.1 million shares** with **gross proceeds of** **$1.6 billion** year-to-date through July 30, 2025[179](index=179&type=chunk) - **Stockholders approved an increase** in authorized common stock from **600 million** to **1.2 billion shares** in May 2025[179](index=179&type=chunk) [New Legislation](index=46&type=section&id=New%20Legislation) The recently signed H.R. 1 Bill **includes** provisions impacting REITs and their investors, such as the permanent extension of the 20% deduction for qualified REIT dividends, an increased asset test limit for TRSs, and a change to the interest deduction limit calculation - H.R. 1 **permanently extended** the **20% deduction** for 'qualified REIT dividends' for individual and non-corporate stockholders[178](index=178&type=chunk) - The Bill **increased the percentage limit** under the REIT asset test applicable to TRSs from **20% to 25%** for taxable years beginning after December 31, 2025[178](index=178&type=chunk) - The **30% interest deduction limit** under Section 163(j) of the Code will apply to Ventas by excluding depreciation, amortization, and depletion from 'adjusted taxable income' (EBITDA-based) for taxable years beginning after December 31, 2024[181](index=181&type=chunk) [Critical Accounting Policies and Estimates](index=48&type=section&id=Critical%20Accounting%20Policies%20and%20Estimates) The financial statements are prepared in accordance with GAAP, requiring management to make estimates and assumptions that affect reported amounts. These estimates are periodically reevaluated, and no material changes to critical accounting policies have occurred in 2025 - Preparation of financial statements requires estimates and assumptions regarding future events, which are based on experience and deemed reasonable under the circumstances[183](index=183&type=chunk) - **No material changes** to critical accounting policies have occurred in 2025[184](index=184&type=chunk) [Recent Accounting Standards](index=48&type=section&id=Recent%20Accounting%20Standards) This section discusses recent FASB and SEC accounting updates, **including** ASU 2023-09 (Income Tax Disclosures), SEC Release No. 33-11275 (Climate-Related Disclosures), and ASU 2024-03 (Disaggregation of Income Statement Expenses), and their **effective** dates and potential impacts on the company's financial statements - ASU 2023-09 (Income Tax Disclosures) is **effective** for fiscal years beginning after December 15, 2024, and Ventas is evaluating its impact[185](index=185&type=chunk) - The SEC's climate-related disclosure rule (SEC Release No. 33-11275) is **effective** for annual reporting periods beginning in fiscal year 2025, but its **implementation is currently stayed** **due to** legal challenges[186](index=186&type=chunk) - ASU 2024-03 (Disaggregation of Income Statement Expenses) is **effective** for annual reporting periods beginning after December 15, 2026, and Ventas is evaluating its impact[187](index=187&type=chunk)[188](index=188&type=chunk) [Results of Operations](index=49&type=section&id=Results%20of%20Operations) This section provides a detailed analysis of Ventas's financial performance for the three and six months ended June 30, 2025, compared to the same periods in 2024, broken down by business segment (SHOP, OM&R, NNN, and Non-segment) and corporate results [Three Months Ended June 30, 2025 and 2024](index=50&type=section&id=Three%20Months%20Ended%20June%2030,%202025%20and%202024) For the three months ended June 30, 2025, Ventas reported a significant increase in net income attributable to common stockholders, **driven by** strong SHOP segment NOI growth and improved performance from unconsolidated entities, despite higher corporate expenses - Same-Store SHOP NOI **increased by** **13.3%** for Q2 2025, **driven by** **higher average occupancy** (**87.6%** vs. **85.2%**) and **revenue per occupied room** (**$5,261** vs. **$4,998**)[197](index=197&type=chunk) - Same-Store OM&R NOI **increased by** **1.0%** for Q2 2025, **primarily due to** **higher average occupancy** (**89.9%** vs. **89.6%**) and **new leasing activity**[200](index=200&type=chunk) - Same-Store NNN NOI **increased by** **2.3%** for Q2 2025, **mainly due to** a net **increase** in contractual rent escalators and timing of rent collection[204](index=204&type=chunk)[205](index=205&type=chunk) | Metric | Q2 2025 (in thousands) | Q2 2024 (in thousands) | Increase (Decrease) to Net Income (in thousands) | % Change | | :-------------------------------------------------------------------------------- | :--------------------- | :--------------------- | :----------------------------------------------- | :------- | | Net income attributable to common stockholders | $68,264 | $19,387 | $48,877 | nm | | Total NOI | $588,126 | $514,354 | $73,772 | **14.3%** | | SHOP NOI | $286,412 | $214,241 | $72,171 | **33.7%** | | OM&R NOI | $146,486 | $146,273 | $213 | **0.1%** | | NNN NOI | $148,736 | $150,428 | $(1,692) | (**1.1%**) | | Non-segment NOI | $6,492 | $3,412 | $3,080 | **90.3%** | | Interest expense | $(150,298) | $(149,259) | $(1,039) | (**0.7%**) | | Depreciation and amortization | $(347,719) | $(339,848) | $(7,871) | (**2.3%**) | | General, administrative and professional fees | $(42,856) | $(37,727) | $(5,129) | (**13.6%**) | | Gain on real estate dispositions | $33,816 | $49,670 | $(15,854) | (**31.9%**) | | Income tax expense | $(3,874) | $(7,766) | $3,892 | **50.1%** | [Six Months Ended June 30, 2025 and 2024](index=56&type=section&id=Six%20Months%20Ended%20June%2030,%202025%20and%202024) For the six months ended June 30, 2025, Ventas experienced a **substantial increase** in net income attributable to common stockholders, **primarily from** robust SHOP segment growth and a **shift to an income tax benefit**, despite **higher depreciation and administrative costs** - Same-Store SHOP NOI **increased by** **14.2%** for YTD Q2 2025, **driven by** **higher average occupancy** (**87.5%** vs. **84.8%**) and **revenue per occupied room** (**$5,229** vs. **$4,997**)[224](index=224&type=chunk) - Same-Store OM&R NOI **increased by** **1.4%** for YTD Q2 2025, **primarily due to** **higher average occupancy** (**89.9%** vs. **89.7%**) and **new leasing activity**[228](index=228&type=chunk) - Same-Store NNN NOI **increased by** **2.0%** for YTD Q2 2025, **mainly due to** a net **increase** in contractual rent escalators and timing of rent collection[230](index=230&type=chunk) | Metric | YTD Q2 2025 (in thousands) | YTD Q2 2024 (in thousands) | Increase (Decrease) to Net Income (in thousands) | % Change | | :-------------------------------------------------------------------------------- | :------------------------- | :------------------------- | :----------------------------------------------- | :------- | | Net income attributable to common stockholders | $115,132 | $5,075 | $110,057 | nm | | Total NOI | $1,157,413 | $1,018,238 | $139,175 | **13.7%** | | SHOP NOI | $550,916 | $417,724 | $133,192 | **31.9%** | | OM&R NOI | $292,528 | $291,842 | $686 | **0.2%** | | NNN NOI | $301,322 | $302,058 | $(736) | (**0.2%**) | | Non-segment NOI | $12,647 | $6,614 | $6,033 | **91.2%** | | Interest expense | $(299,654) | $(299,192) | $(462) | (**0.2%**) | | Depreciation and amortization | $(669,244) | $(640,103) | $(29,141) | (**4.6%**) | | General, administrative and professional fees | $(96,005) | $(86,464) | $(9,541) | (**11.0%**) | | Gain on real estate dispositions | $33,985 | $50,011 | $(16,026) | (**32.0%**) | | Income tax benefit (expense) | $6,683 | $(4,762) | $11,445 | nm | [Non-GAAP Financial Measures](index=60&type=section&id=Non-GAAP%20Financial%20Measures) This section presents non-GAAP financial measures, **including** Nareit Funds From Operations (FFO) and Normalized FFO attributable to common stockholders, and Net Operating Income (NOI), which management uses to evaluate operating performance and provide investors with supplemental insights into the company's real estate operations [Nareit Funds From Operations and Normalized Funds From Operations Attributable to Common Stockholders](index=61&type=section&id=Nareit%20Funds%20From%20Operations%20and%20Normalized%20Funds%20From%20Operations%20Attributable%20to%20Common%20Stockholders) FFO and Normalized FFO are key supplemental measures for REITs, excluding real estate depreciation, amortization, and gains/losses on sales, to provide a clearer view of operating performance. Normalized FFO further adjusts for non-recurring or non-cash items - FFO is defined by Nareit as net income attributable to common stockholders, excluding gains/losses from real estate sales, impairment write-downs, and adding back real estate depreciation and amortization, with adjustments for unconsolidated entities and noncontrolling interests[247](index=247&type=chunk) - Normalized FFO further excludes items like gains/losses on derivatives, non-cash income tax impacts, debt extinguishment gains/losses, transaction costs, and other normalizing items[247](index=247&type=chunk) | Metric | Q2 2025 (in thousands) | Q2 2024 (in thousands) | YTD Q2 2025 (in thousands) | YTD Q2 2024 (in thousands) | | :------------------------------------------ | :--------------------- | :--------------------- | :------------------------- | :------------------------- | | Nareit FFO attributable to common stockholders | $395,343 | $317,192 | $774,102 | $610,096 | | Normalized FFO attributable to common stockholders | $400,143 | $329,119 | $776,865 | $645,694 | [NOI](index=63&type=section&id=NOI) Net Operating Income (NOI) is a non-GAAP measure used to assess unlevered property-level operating results and compare performance across periods. It is defined as total revenues less interest and other income, property-level operating expenses, and third-party capital management expenses - NOI is considered an **important supplemental measure** for assessing unlevered property-level operating results and comparing performance consistently across periods[250](index=250&type=chunk) - Same-Store NOI **includes** properties owned, consolidated, and operational for the full comparison periods, with specific criteria for **including** newly acquired, developed, or transitioned properties[252](index=252&type=chunk) | Metric | Q2 2025 (in thousands) | Q2 2024 (in thousands) | YTD Q2 2025 (in thousands) | YTD Q2 2024 (in thousands) | | :----- | :--------------------- | :--------------------- | :------------------------- | :------------------------- | | NOI | $588,126 | $514,354 | $1,157,413 | $1,018,238 | [Concentration Risk](index=64&type=section&id=Concentration%20Risk) Ventas evaluates concentration risk by analyzing its investment mix (by asset type) and operations mix (by manager/tenant and geographic location) to understand potential impacts of economic downturns or adverse events | Asset Type | Investment Mix (June 30, 2025) | Investment Mix (December 31, 2024) | | :--------------------------------- | :----------------------------- | :--------------------------------- | | Senior housing communities | **68.3%** | **67.3%** | | Outpatient medical buildings | **19.0%** | **19.7%** | | Research centers | **5.7%** | **5.3%** | | Other healthcare facilities | **4.4%** | **4.5%** | | IRFs and LTACs | **1.9%** | **2.0%** | | Skilled nursing facilities (SNFs) | **0.7%** | **1.2%** | [Triple-Net Lease Performance and Expirations](index=66&type=section&id=Triple-Net%20Lease%20Performance%20and%20Expirations) This section discusses the risks associated with triple-net leases, **including** tenant defaults and non-renewals, and provides a summary of lease expirations for OM&R and NNN segments over the next decade and beyond - **Tenant failures or non-renewals** of triple-net leases could **adversely affect** Ventas, as repositioning properties on favorable terms may be challenging[259](index=259&type=chunk) - During the six months ended June 30, 2025, there were **no material triple-net lease renewals or expirations** without renewal[259](index=259&type=chunk) | Expiration Year | OM&R Annualized Base Rent (in thousands) | NNN Annualized Base Rent (in thousands) | % of Total OM&R and NNN Annualized Base Rent | | :-------------- | :--------------------------------------- | :-------------------------------------- | :------------------------------------------- | | 2025 | $38,484 | $66,308 | **9%** | | 2026 | $62,345 | $40,556 | **9%** | | 2027 | $87,855 | $10,518 | **9%** | | 2028 | $71,142 | $46,571 | **10%** | | 2029 | $74,117 | $11,870 | **8%** | | 2030 | $58,713 | $87,115 | **13%** | | Thereafter | $58,019 | $208,710 | **23%** | [Liquidity and Capital Resources](index=66&type=section&id=Liquidity%20and%20Capital%20Resources) Ventas's liquidity is **primarily derived from** cash flows from operations, debt and equity issuances, and credit facilities. The company's principal liquidity needs **include** funding operating expenses, debt service, acquisitions, and capital expenditures, which are expected to be met through a combination of internal and external capital sources - **Principal liquidity sources** **include** cash flows from operations, proceeds from debt and equity issuances, borrowings under credit facilities, and asset sales[263](index=263&type=chunk) - **Key liquidity needs** for the next 12 months **include** funding operating expenses, debt service, acquisitions, development, capital expenditures, and stockholder distributions[264](index=264&type=chunk) - As of June 30, 2025, the **$3.5 billion** unsecured revolving credit facility had **$1.4 million** **outstanding** and **$0.8 million** **restricted for letters of credit**[267](index=267&type=chunk) - Ventas Realty has **$862.5 million** in **3.75%** Exchangeable Senior Notes due 2026 **outstanding**, exchangeable at **$54.76** per share[272](index=272&type=chunk)[274](index=274&type=chunk) - During the six months ended June 30, 2025, net cash **provided by** operating activities **increased by** **$194.2 million**, while net cash **used in** investing activities **increased by** **$676.8 million** **due to** higher real estate investments[297](index=297&type=chunk)[298](index=298&type=chunk) - Financing activities **shifted from a net cash use** in 2024 to a **net cash provision** in 2025, **primarily due to a** **$573.0 million** **increase** in common stock issuances, **partially offset by a** **$427.5 million** net **decrease** in debt[299](index=299&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=74&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) This section discusses Ventas's exposure to market risks, **primarily related to** changes in interest rates and foreign currency exchange rates. It details the company's debt structure, weighted average interest rates, and sensitivity analysis for interest rate fluctuations - Ventas is **primarily exposed to market risk** from changes in interest rates on variable rate debt and foreign currency exchange rates **due to** Canadian and UK operations[307](index=307&type=chunk)[315](index=315&type=chunk) - A **hypothetical 100 basis point increase** in the weighted average interest rate on variable rate debt would **increase annualized interest expense by approximately** **$12.2 million**, or **$0.03** per diluted common share[311](index=311&type=chunk) - The **fair value of fixed rate debt is sensitive** to market interest rate changes, but these changes **do not affect current interest expense** until maturity or refinancing[313](index=313&type=chunk) | Debt Type | Balance (June 30, 2025, in thousands) | Percentage of Total Debt (June 30, 2025) | Weighted Average Interest Rate (June 30, 2025) | | :--------------------------------- | :------------------------------------ | :--------------------------------------- | :--------------------------------------------- | | Fixed rate debt | $11,933,875 | **90.8%** | **4.2%** (Senior notes/Exchangeable senior notes) | | Variable rate debt | $1,220,999 | **9.2%** | **5.0%** (Unsecured revolving credit facility) | | Total | $13,154,874 | **100.0%** | **4.3%** | [Item 4. Controls and Procedures](index=77&type=section&id=Item%204.%20Controls%20and%20Procedures) Management, **including** the CEO and CFO, evaluated the **effectiveness** of Ventas's disclosure controls and procedures as of June 30, 2025, concluding they were **effective**. There were **no material changes** in internal control over financial reporting during the second quarter of 2025 - The Chief Executive Officer and Chief Financial Officer **concluded that disclosure controls and procedures were effective** as of June 30, 2025[316](index=316&type=chunk) - **No material changes in internal controls** over financial reporting occurred during the second quarter of 2025[317](index=317&type=chunk) PART II—OTHER INFORMATION [Item 1. Legal Proceedings](index=78&type=section&id=Item%201.%20Legal%20Proceedings) This section incorporates by reference the information on commitments and contingencies from Note 12 of the Consolidated Financial Statements, stating that there have been **no new material legal proceedings** or developments since the 2024 Annual Report - **No new material legal proceedings** or material developments in reported legal proceedings occurred in the second quarter of 2025[319](index=319&type=chunk) [Item 1A. Risk Factors](index=78&type=section&id=Item%201A.%20Risk%20Factors) This section states that there were **no significant new risk factors** identified in the second quarter of 2025 beyond those disclosed in the 2024 Annual Report - **No significant new risk factors** were identified in the second quarter of 2025 compared to the 2024 Annual Report[320](index=320&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=78&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) This section summarizes the issuer's purchases of equity securities during the quarter ended June 30, 2025, which **primarily represent** shares withheld to cover taxes on vesting restricted stock and stock option exercises - **Repurchases represent shares withheld** to pay taxes on the vesting of restricted stock and restricted stock units, and/or to pay taxes on the exercise price of stock options[321](index=321&type=chunk) | Period | Number of Shares Repurchased | Average Price Per Share | | :-------------------- | :--------------------------- | :---------------------- | | April 1 through April 30 | 24,054 | $65.56 | | May 1 through May 31 | 508 | $66.43 | | June 1 through June 30 | 1,086 | $64.28 | | Total | 25,648 | $65.52 | [Item 3. Defaults Upon Senior Securities](index=78&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities) This item is marked as **not applicable**, **indicating no defaults** upon senior securities during the reporting period - **This item is not applicable**, **indicating no defaults** upon senior securities[322](index=322&type=chunk) [Item 4. Mine Safety Disclosures](index=78&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) This item is marked as **not applicable**, as the company does not have operations requiring mine safety disclosures - **This item is not applicable**[323](index=323&type=chunk) [Item 5. Other Information](index=78&type=section&id=Item%205.%20Other%20Information) This section states that during the three months ended June 30, 2025, **none of** the company's directors or officers adopted, terminated, or modified any Rule 10b5-1 or non-Rule 10b5-1 trading arrangements - **No directors or officers adopted, terminated, or modified** Rule 10b5-1 or non-Rule 10b5-1 trading arrangements during the three months ended June 30, 2025[324](index=324&type=chunk) [Item 6. Exhibits](index=79&type=section&id=Item%206.%20Exhibits) This section lists all exhibits filed as part of the Form 10-Q, **including** the Restated Certificate of Incorporation, Supplemental Indenture, certifications, and XBRL data - Exhibits **include** the Restated Certificate of Incorporation, Tenth Supplemental Indenture, List of Guarantors and Issuers of Guaranteed Securities, and various certifications (31.1, 31.2, 32.1, 32.2)[327](index=327&type=chunk) - The report **includes** **XBRL formatted financial statements** and a **Cover Page Interactive Data File**[327](index=327&type=chunk)
Ventas Q2 FFO and Revenues Top Estimates, Same-Store Cash NOI Rises
ZACKS· 2025-07-31 18:11
Core Insights - Ventas, Inc. (VTR) reported second-quarter 2025 normalized funds from operations (FFO) per share of 87 cents, exceeding the Zacks Consensus Estimate of 85 cents, marking a 9% increase year-over-year [1][8] - The company achieved revenues of $1.42 billion in the second quarter, surpassing the Zacks Consensus Estimate of $1.37 billion, and reflecting an 18.3% year-over-year growth [2][8] - Ventas has raised its guidance for 2025 normalized FFO per share to a range of $3.41-$3.46, compared to the previous range of $3.36-$3.46 [7][9] Financial Performance - Same-store cash net operating income (NOI) for the total property portfolio increased by 6.6% year-over-year to $485.3 million [2][4] - The senior housing operating portfolio (SHOP) saw a 13.3% increase in same-store cash NOI year-over-year, reaching $226.1 million, supported by a 5.3% growth in average monthly revenues per occupied room [4][8] - The outpatient medical and research (OM&R) portfolio's same-store cash NOI improved by 1.7% year-over-year to $135.9 million, while the triple-net leased portfolio's same-store cash NOI rose by 1% to $123.4 million [5][8] Balance Sheet and Liquidity - Ventas ended the second quarter of 2025 with cash and cash equivalents of $614.2 million, a significant increase from $182.3 million as of March 31, 2025 [6] - The company reported $4.7 billion of liquidity at the end of the quarter, up from $2.9 billion as of March 31, 2025, with a net debt to further adjusted EBITDA ratio of 5.6 [6] Future Guidance - The total same-store cash NOI growth for 2025 is estimated to be between 6% and 8%, with the SHOP segment expected to grow between 12% and 16% [7][9] - The OM&R portfolio's same-store cash NOI is projected to grow between 2.25% and 2.75%, while the triple-net leased same-store cash NOI is expected to decline between negative 1.0% and negative 0.5% [9]